CNBX Pharmaceuticals Inc.
CNBX· OTC
CNBXCNBX Pharmaceuticals Inc.
Filed Jan 22, 2016 · 10-Q · 53 days after period end · 0001019687-16-004908
| Metric | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 |
|---|---|---|---|---|
| Net Income | -$55.26K | -$127.66K | -$13.34K | -$15.14K |
| EPS Diluted | -$0.00 | $0.00 | $0.00 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR
ended Nov 30, 2015 · filed Jan 22, 2016 · 53 d after period end
